FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) By Effective Medicine On January 10, 2013March 10, 2017 In Drugs Tagged fda, new drugs facebook tweet google+ questions and answers to provide an additional overview of this safety issue.